Cancer risks: drugs pull antihypertensives

for every Newsroom/OCorreio Portal

7 March 2022

Credit: Disclosure

Pharmaceutical company Sanofi Medley announced that it will do so Collect all batches of Medley brand antihypertensive drugs. The pharmaceutical company announced the recall after noticing the presence of mutagenic impurities in the products, which can pose a health risk to users.

The impurities, according to the company, may cause changes to users’ DNA, increasing the long-term potential for cancer. However, he points out, the exact danger of this potentially carcinogenic chemical in humans remains unknown.

The products collected are:

losartan potassium + hydrochlorothiazide 50 mg + 12.5 mg;
Losartan potassium + hydrochlorothiazide 100 mg + 25 mg;
losartan potassium 50 mg;
Losartan Potassium 100 mg.

Returns are voluntary and the return process is free for consumers. However, it is important to consult your doctor to advise on the return and follow-up of treatment.

Anyone with any combination of these products, just call Medley’s SAC: 0800-703-0014.

Check out the full statement:

ccall notice

São Paulo, February 10, 2022 – Sanofi Medley Farmacêutica Ltda notifies voluntary returns of all product groups: Valtrian® HCT (Losartan Potassium + Hydrochlorothiazide) 50 mg + 12.5 mgAnd the Valtrian® 50 mg and 100 mg (losartan potassium) tablets.

This voluntary recall is performed by Sanofi Medley as a precaution due to the presence of mutagenic impurities in the products.

A mutagenic impurity is a chemical substance that can cause a change in the DNA of a cell. These mutations may increase the long-term risk of cancer, but the specific risk of these carcinogenic inclusions in humans is currently unknown.

This kit does not represent a cost to patients. If you own any combination of these products, call Medley Customer Service at 0800-703-0014. In case of doubt about treatment, consult a doctor.

It is considered,

Sanofi Medley Pharmaceuticals